Blood

Journal Title：Blood

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal.

《血液》是美国血液学会的官方期刊，以在线和印刷形式出版，为发表描述血液学基础实验室、转化和临床研究的原创文章提供了一个国际论坛。稿件的接受基于观察或调查的原创性和重要性、工作质量和证据的有效性、表达的清晰度以及与读者和领域的相关性。所有文章都应简洁、组织良好且写得清楚。作者提交稿件时应了解稿件（或其基本内容）未以任何语言或格式以摘要以外的形式发表过，并且目前未提交给其他地方进行印刷或电子出版。

主要研究文章将发表在以下科学类别下：临床试​​验和观察；基因治疗；造血和干细胞；免疫生物学和免疫治疗范围；髓系肿瘤；淋巴系肿瘤；吞噬细胞、粒细胞和髓系细胞生成；血小板和血栓形成；红细胞、铁和红细胞生成；血栓形成和止血；输血医学；移植；血管生物学。论文可以根据需要列在多个类别下。如果作者不确定他们的工作是否属于该期刊的一般范围，请在提交前联系主编。

Blood创刊于1946年，由American Society of Hematology出版商出版，收稿方向涵盖医学 - 血液学全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度 约1.0个月 ，影响因子指数21，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。